Evolent Health EPS EVH
Diluted earnings per share by quarter and over the last twelve months, from 2014.
- Last 12 months, to Jun 30, 2026
- −$4.57
- Latest quarter, Q2 FY26
- −$0.25
- Fiscal year 2025
- −$5.15
Evolent Health's earnings per share was −$4.57 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.25.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$5.15 | n/a |
| FY2024 | −$0.82 | n/a |
| FY2023 | −$1.27 | n/a |
| FY2022 | −$0.20 | n/a |
| FY2021 | −$0.44 | n/a |
| FY2020 | −$3.92 | n/a |
| FY2019 | −$3.63 | n/a |
| FY2018 | −$0.68 | n/a |
| FY2017 | −$0.98 | n/a |
| FY2016 | −$3.70 | −172% |
| FY2015 | $5.12 | n/a |
| FY2014 | −$13.03 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.25 | n/a | −$4.57 | |
| Q1 FY26 | −$0.24 | n/a | −$4.76 | |
| Q4 FY25 | −$3.84 | n/a | −$5.15 | |
| Q3 FY25 | −$0.24 | n/a | −$1.58 | |
| Q2 FY25 | −$0.44 | n/a | −$1.61 | |
| Q1 FY25 | −$0.63 | n/a | −$1.23 | |
| Q4 FY24 | −$0.27 | n/a | −$0.82 | |
| Q3 FY24 | −$0.27 | n/a | −$0.91 | |
| Q2 FY24 | −$0.06 | n/a | −$0.94 | |
| Q1 FY24 | −$0.22 | n/a | −$1.25 | |
| Q4 FY23 | −$0.36 | n/a | −$1.27 | |
| Q3 FY23 | −$0.30 | −1600% | −$1.02 |
Against its peers
Companies in Specialty Business Services nearest Evolent Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| EVHEvolent Health | −$4.57 | |
| CRAICRA International | $7.51 | −9% a year |
| DFINDonnelley Financial Solutions | $1.45 | −49% a year |
| FCFranklin Covey | $0.17 | −78% a year |
| VVXV2X | $2.90 | +32% a year |
| MHMcGraw Hill | $0.50 | |
| Peer median | $1.45 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Evolent Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.